Literature DB >> 11005710

Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism.

F Paulsen1, U Hallmann, J Paulsen, A Thale.   

Abstract

The lacrimal sac and nasolacrimal duct are surrounded by a wide cavernous system of veins and arteries comparable to a cavernous body. The present study aimed to demonstrate the ultrastructure of the nervous tissue and the localisation of neuropeptides involved in the innervation of the cavernous body, a topic not previously investigated. Different S-100 protein antisera, neuronal markers (neuron-specific enolase, anti-200 kDa neurofilament), neuropeptides (substance P, neuropeptide Y, calcitonin gene-related peptide, vasoactive intestinal polypeptide) and the neuronal enzyme tyrosine hydroxylase were used to demonstrate the distribution pattern of the nervous tissue. The ultrastructure of the innervating nerve fibres was also examined by means of standard transmission electron microscopy. The cavernous body contained specialised arteries and veins known as barrier arteries, capacitance veins, and throttle veins. Perivascularly, the tissue was rich in myelinated and unmyelinated nerve fibres in a plexus-like network. Small seromucous glands found in the region of the fundus of the lacrimal sac were contacted by nerve fibres forming a plexus around their alveoli. Many nerve fibres were positive for S-100 protein (S 100), neuron-specific enolase (NSE), anti-200 kDa neurofilament (RT 97), calcitonin gene-related peptide (CGRP), substance P (SP), tyrosine hydroxylase (TH), and neuropeptide Y (NPY). Vasoactive intestinal polypeptide (VIP) immunoreactivity was only demonstrated adjacent to the seromucous glands. Both the density of nerve fibres as well as the presence of various neuropeptides emphasises the neural control of the cavernous body of the human efferent tear ducts. By means of this innervation, the specialised blood vessels permit regulation of blood flow by opening and closing the lumen of the lacrimal passage as effected by the engorgement and subsidence of the cavernous body, at the same time regulating tear outflow. Related functions such as a role in the occurrence of epiphora related to emotional responses are relevant. Moreover, malfunction in the innervation of the cavernous body may lead to disturbances in the tear outflow cycle, ocular congestion or total occlusion of the lacrimal passages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005710      PMCID: PMC1468117          DOI: 10.1046/j.1469-7580.2000.19720177.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  38 in total

1.  An anatomical approach to problems of the eyelids and lacrimal apparatus.

Authors:  L T JONES
Journal:  Arch Ophthalmol       Date:  1961-07

2.  Effect of substance P and eledoisin on K+ efflux, amylase release and cyclic nucleotide levels in slices of rat parotid gland.

Authors:  L Rudich; F R Butcher
Journal:  Biochim Biophys Acta       Date:  1976-10-22

3.  Concept of paraneurons.

Authors:  T Fujita
Journal:  Arch Histol Jpn       Date:  1977

4.  The lacrimal drainage system: pressure changes in the canaliculus.

Authors:  G Wilson; R Merrill
Journal:  Am J Optom Physiol Opt       Date:  1976-02

5.  Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells.

Authors:  D Schmechel; P J Marangos; M Brightman
Journal:  Nature       Date:  1978 Dec 21-28       Impact factor: 49.962

6.  Lacrimal drainage--a dynamic evaluation. Part I--mechanics of tear transport.

Authors:  J C Hill; W Bethell; H J Smirmaul
Journal:  Can J Ophthalmol       Date:  1974-10       Impact factor: 1.882

7.  Electron microscopy of the nasal vascular bed and its nerve supply.

Authors:  N Cauna
Journal:  Ann Otol Rhinol Laryngol       Date:  1970-06       Impact factor: 1.547

8.  The fine structure and innervation of the cushion veins of the human nasal respiratory mucosa.

Authors:  N Cauna; D Cauna
Journal:  Anat Rec       Date:  1975-01

9.  Substance P in the superior cervical ganglion and the submaxillary gland of the rat.

Authors:  S E Robinson; J P Schwartz; E Costa
Journal:  Brain Res       Date:  1980-01-20       Impact factor: 3.252

10.  Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: functional significance of coexisting transmitters for vasodilation and secretion.

Authors:  J M Lundberg; A Anggård; J Fahrenkrug; T Hökfelt; V Mutt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

View more
  7 in total

1.  Ultrasonic visualization of the effect of blinking on the lacrimal pump mechanism.

Authors:  Mitrofanis Pavlidis; Tobias Stupp; Ulrike Grenzebach; Holger Busse; Solon Thanos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-29       Impact factor: 3.117

2.  Evidence for unmyelinated C fibres and inflammatory cells in human varicose saphenous vein.

Authors:  Anne Vital; Dominique Carles; Jean-Michel Serise; Michel René Boisseau
Journal:  Int J Angiol       Date:  2010

Review 3.  [Anatomy and physiology of the nasolacrimal ducts].

Authors:  F Paulsen; F Garreis; M Schicht; L Bräuer; M J Ali; S Sel
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

4.  Detection of intrinsic cholinergic system in the human lacrimal drainage system: evidence and potential implications.

Authors:  Mohammad Javed Ali; Mareile Glóckner; Martin Schicht; Lars Bräuer; Friedrich Paulsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-09-03       Impact factor: 3.117

5.  Rhinological Status of Patients with Nasolacrimal Duct Obstruction.

Authors:  Vasily D Yartsev; Eugenia L Atkova; Eugeniy O Rozmanov; Nina D Yartseva
Journal:  Int Arch Otorhinolaryngol       Date:  2021-12-20

6.  Effects of adrenergic and cholinergic antagonists on diameter of nasolacrimal drainage system.

Authors:  Junji Narioka; Yuichi Ohashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-20       Impact factor: 3.117

Review 7.  Understanding the symptoms of the common cold and influenza.

Authors:  Ron Eccles
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.